ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $228,276 | -20.4% | 34,173 | 0.0% | 0.06% | -22.1% |
| Q2 2023 | $286,711 | -15.5% | 34,173 | 0.0% | 0.08% | -23.0% |
| Q1 2023 | $339,338 | +42.7% | 34,173 | 0.0% | 0.10% | +28.2% |
| Q4 2022 | $237,844 | +30.7% | 34,173 | 0.0% | 0.08% | +21.9% |
| Q3 2022 | $182,000 | +33.8% | 34,173 | 0.0% | 0.06% | +39.1% |
| Q2 2022 | $136,000 | -10.5% | 34,173 | 0.0% | 0.05% | -11.5% |
| Q1 2022 | $152,000 | -49.3% | 34,173 | 0.0% | 0.05% | -53.6% |
| Q3 2021 | $300,000 | -22.5% | 34,173 | 0.0% | 0.11% | -26.8% |
| Q2 2021 | $387,000 | -4.7% | 34,173 | 0.0% | 0.15% | -11.0% |
| Q1 2021 | $406,000 | +73.5% | 34,173 | 0.0% | 0.17% | +60.7% |
| Q4 2020 | $234,000 | -7.5% | 34,173 | 0.0% | 0.11% | -23.0% |
| Q3 2020 | $253,000 | +76.9% | 34,173 | 0.0% | 0.14% | +65.5% |
| Q2 2020 | $143,000 | +70.2% | 34,173 | 0.0% | 0.08% | +37.7% |
| Q1 2020 | $84,000 | – | 34,173 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 124,096 | $583,000 | 0.77% |
| SPHERA FUNDS MANAGEMENT LTD. | 875,931 | $4,117,000 | 0.70% |
| Perceptive Advisors | 2,885,458 | $13,417,000 | 0.68% |
| 683 Capital Management, LLC | 525,093 | $2,442,000 | 0.36% |
| Hikari Power Ltd | 107,858 | $507,000 | 0.07% |
| SABBY MANAGEMENT, LLC | 97,704 | $454,000 | 0.03% |
| Weiss Multi-Strategy Advisers LLC | 62,000 | $288,000 | 0.01% |
| ARDSLEY ADVISORY PARTNERS LP | 29,104 | $136,000 | 0.01% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 475,000 | $2,209,000 | 0.01% |
| Virtu KCG Holdings LLC | 22,431 | $104,000 | 0.00% |